The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.20
Bid: 172.00
Ask: 172.40
Change: 0.60 (0.35%)
Spread: 0.40 (0.233%)
Open: 174.00
High: 174.20
Low: 171.40
Prev. Close: 171.60
IBST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Aug 2019 10:26

RNS Number : 5564H
Ibstock PLC
01 August 2019
 

1 August 2019

 

Ibstock plc

 

Director Change

 

 

Further to the announcement issued on 6 February 2019, Ibstock plc ('Ibstock' or the 'Company') announces that Chris McLeish has today been appointed a director of the Company.

 

Enquiries

Citigate Dewe Rogerson

Kevin Smith

Nick Hayns

+ 44 (0)20 7638 9571

 

 

 Notes to Editors:

Remuneration:

Chris McLeish's remuneration arrangements, which are consistent with the Directors' Remuneration Policy approved by shareholders, will take effect from 1 August 2019, as summarised below:

·;

Base salary - £300,000 p.a.;

·;

Pension - 10% of salary cash allowance;

·;

Annual bonus opportunity - up to 125% of salary; and

·;

Long Term Incentive Plan - 125% of salary for 2019 (normal award for 2019 is 100% of salary for Executive Directors). The increased quantum for 2019 was negotiated as part of Mr McLeish's recruitment from Tate & Lyle plc in lieu of one of the Tate & Lyle share awards which is not otherwise covered under the buy-out arrangements. From 2020 onwards awards of 150% of salary will be made, subject to performance

Chris also held a number of cash and share incentives under various Tate & Lyle plc incentive plans. In line with the approved Directors' Remuneration Policy, replacement awards form part of the recruitment remuneration.

A cash payment of £97,949 will be made to Chris on appointment to compensate the value of his 2018 annual bonus earned which was forfeited on cessation.

In addition, it has been agreed to grant a buy-out award of 60,393 Ibstock plc ordinary shares of 1p each. The award is to compensate, on a fair value basis, the value forgone by Chris McLeish for share awards forfeited on cessation of employment with his previous employer. The fair value of the award has been reduced to take account of the original performance period and the proportion of satisfaction of the performance conditions as at the time of the buy-out. The vesting level will be revisited at the time of vesting to adjust the number of Ibstock shares which vest to reflect the actual vesting of the original Tate & Lyle awards.

Full disclosure of these remuneration arrangements will be provided in the Directors' Remuneration Report to be published in 2020.

Ibstock plc is a leading manufacturer of clay bricks with a diversified range of clay and concrete products, and operations in the United Kingdom and the United States. Its principal products are clay bricks, brick components, concrete roof tiles, concrete substitutes for stone masonry, concrete fencing and general concrete building products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEANPFEASNEEF
Date   Source Headline
18th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
6th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20229:54 amRNSTotal Voting Rights
4th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSDirectorate Change
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:00 amRNSTransaction in Own Shares
19th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
15th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSTransaction in Own Shares
13th Sep 20227:00 amRNSTransaction in Own Shares
12th Sep 20227:00 amRNSTransaction in Own Shares
9th Sep 20227:00 amRNSTransaction in Own Shares
8th Sep 20227:00 amRNSTransaction in Own Shares
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
5th Sep 20227:00 amRNSTransaction in Own Shares
2nd Sep 20227:00 amRNSTransaction in Own Shares
1st Sep 20227:00 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSTransaction in Own Shares
31st Aug 20227:00 amRNSTransaction in Own Shares
30th Aug 20223:15 pmRNSHolding(s) in Company
30th Aug 202212:00 pmRNSShare Buyback Programme Update
30th Aug 20227:00 amRNSTransaction in Own Shares
26th Aug 20227:00 amRNSTransaction in Own Shares
25th Aug 20227:00 amRNSTransaction in Own Shares
24th Aug 20227:00 amRNSTransaction in Own Shares
23rd Aug 20227:00 amRNSTransaction in Own Shares
22nd Aug 20227:00 amRNSTransaction in Own Shares
19th Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares
17th Aug 20227:00 amRNSTransaction in Own Shares
16th Aug 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.